Delivery Order SPE2DB22D2005-SPE2DB25FJNP6

Award Date 6/12/25
Potential Completion Date 7/7/25
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of PROQUAD VIALS to the Defense Logistics Agency (DLA). The $2,686.44 firm fixed-price delivery order has a completion date of July 10, 2025 and is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,740.49 firm-fixed-price delivery order is for the procurement of 4,568,032,234 PROQUAD VIALS. The contract has an ultimate completion date of May 13, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,012.70 firm fixed-price delivery order is for PROQUAD VIALS, with an ultimate completion date of April 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $3,374.96 and a completion date of July 9, 2025. The contract is for the supply of "PROQUAD VIALS" medical products, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,086.60 firm fixed-price delivery order is for the supply of 4568267436 PROQUAD VIALS, a pharmaceutical product, with a performance period extending through June 4, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,341.80 firm fixed-price delivery order is for PROQUAD VIALS, with an ultimate completion date of June 26, 2025. The contract is not set-aside and allows for the supply of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,115.18 firm fixed-price delivery order is for PROQUAD VIALS (4561630029) and has an ultimate completion date of August 11, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $3,374.96 fixed-price delivery order is for the supply of PROQUAD VIALS, with a performance period ending on July 1, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,012.70 firm fixed-price delivery order is for PROQUAD VIALS, with a completion date of June 12, 2025. The contract is not set aside and represents an order under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides global pharmaceutical support to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA). The $2,740.49 firm fixed-price delivery order does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle to supply a wide...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB25FJNP6
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,686.44 firm fixed-price delivery order is for the supply of PROQUAD VIALS, with a completion date of July 7, 2025. The contract is not designated as a set-aside.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/11/25, 10:44 AM